Sign up to save your podcasts
Or
Share Pharma and Biotech Daily: RFK Jr. Accused of Spreading Mistrust, J&J Increases US Manufacturing, Fedegari Becomes One-Stop Solution Provider
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pharma and Biotech Daily: RFK Jr. Accused of Spreading Mistrust, J&J Increases US Manufacturing, Fedegari Becomes One-Stop Solution Provider
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. HHS employees have accused RFK Jr. of spreading public mistrust against the CDC after a shooting at their headquarters. They have asked him to stop spreading health misinformation, especially about vaccines and infectious diseases. In other news, Johnson & Johnson has added $2 billion to their US manufacturing commitment amid Trump's tariff threats. Regeneron's Eylea HD decisions have been delayed, and Stealth Biotherapeutics' rejected Barth drug is returning to the FDA for review. Fedegari is now a one-stop solution provider for the pharmaceutical industry, offering highly customized solutions for sterile drug production. Additionally, the American pharma industry is facing challenges with tariffs and policy changes. Several upcoming webinars and job opportunities in the pharmaceutical industry are also highlighted in the newsletter.
View all episodes
By Pharma and BioTech News
3.6
1111 ratings
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. HHS employees have accused RFK Jr. of spreading public mistrust against the CDC after a shooting at their headquarters. They have asked him to stop spreading health misinformation, especially about vaccines and infectious diseases. In other news, Johnson & Johnson has added $2 billion to their US manufacturing commitment amid Trump's tariff threats. Regeneron's Eylea HD decisions have been delayed, and Stealth Biotherapeutics' rejected Barth drug is returning to the FDA for review. Fedegari is now a one-stop solution provider for the pharmaceutical industry, offering highly customized solutions for sterile drug production. Additionally, the American pharma industry is facing challenges with tariffs and policy changes. Several upcoming webinars and job opportunities in the pharmaceutical industry are also highlighted in the newsletter.
More shows like Pharma and BioTech Daily
View all
WSJ Tech News Briefing
1,646 Listeners
NPR News Now
14,199 Listeners
WSJ Your Money Briefing
1,714 Listeners
Planet Money
30,695 Listeners
Bloomberg Businessweek
429 Listeners
WSJ Minute Briefing
662 Listeners
Equity
339 Listeners
The Long Run with Luke Timmerman
122 Listeners
The Indicator from Planet Money
9,514 Listeners
The Readout Loud
316 Listeners
The Journal.
5,960 Listeners
BioCentury This Week
30 Listeners
Biotech Hangout
17 Listeners
The Wall Street Skinny
214 Listeners
WSJ's Take On the Week
127 Listeners